Carlsmed, Inc. Insider Trading

CARL

Last 12 months

Insiders sold $2.66M and bought nothing on the open market.

1% of the selling was scheduled in advance under 10b5-1 plans. CEO, President Michael Cordonnier sold $2.63M on Mar 2, 11% of their stake, outside a plan. The last open-market buy by an executive or director was in Jul 2025.

Net open-market

−$2.66M

0 buys · 5 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jul 2025

Jul 24, 2025

Get an email when CARL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 3	Jeffrey Bertolini Chief Operating Officer	Sold10b5-1 plan	747	$15.15	11K	3.2%	Form 4
Oct 30	Jeffrey Bertolini Chief Operating Officer	Sold10b5-1 plan	243	$15.80	4K	1.1%	Form 4
Oct 5	Jeffrey Bertolini Chief Operating Officer	Sold10b5-1 plan	747	$14.39	11K	3.2%	Form 4
Sep 30	Jeffrey Bertolini Chief Operating Officer	Sold10b5-1 plan	243	$13.99	3K	1.1%	Form 4
Mar 2	Michael Cordonnier CEO, President	SoldNo plan	197,855	$13.29	$2.63M	11%	Form 4
Jul 24, 2025	Casey M Tansey Large holder	Bought	200,000	$15.00	$3M	New	Form 4
Jul 24, 2025	B Capital Healthcare I, L.p. Large holder	Bought	1,333,333	$15.00	$20M	19%	Form 4
Jul 24, 2025	Kevin Sidow Director	Bought	13,333	$15.00	200K	29%	Form 4
Jul 24, 2025	Robert Mittendorff II Director	Bought	1,333,333	$15.00	$20M	New	Form 4
Jul 24, 2025	Jonathan D Root Director	Bought	466,666	$15.00	$7M	34%	Form 4
Jul 24, 2025	Philip M Young Director	Bought 2 parts	59,999	$15.00 average	900K	130%	Form 4

Nov 310b5-1 plan
Jeffrey Bertolini
Chief Operating Officer · sold 747 at $15.15
11K
3.2% of stake
Oct 3010b5-1 plan
Jeffrey Bertolini
Chief Operating Officer · sold 243 at $15.80
4K
1.1% of stake
Oct 510b5-1 plan
Jeffrey Bertolini
Chief Operating Officer · sold 747 at $14.39
11K
3.2% of stake
Sep 3010b5-1 plan
Jeffrey Bertolini
Chief Operating Officer · sold 243 at $13.99
3K
1.1% of stake
Mar 2No plan
Michael Cordonnier
CEO, President · sold 197,855 at $13.29
$2.63M
11% of stake
Jul 24, 2025
Casey M Tansey
Large holder · bought 200,000 at $15.00
$3M
New position
Jul 24, 2025
B Capital Healthcare I, L.p.
Large holder · bought 1,333,333 at $15.00
$20M
19% of stake
Jul 24, 2025
Kevin Sidow
Director · bought 13,333 at $15.00
200K
29% of stake
Jul 24, 2025
Robert Mittendorff II
Director · bought 1,333,333 at $15.00
$20M
New position
Jul 24, 2025
Jonathan D Root
Director · bought 466,666 at $15.00
$7M
34% of stake
Jul 24, 2025
Philip M Young
Director · bought 59,999 at avg $15.00
900K
130% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CARL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with CARL

CompareIntrinsic value

LNSRLensar Inc.

$5.84+4.85%40

CVRXCVRx, Inc.

$1.58+14.49%40

VEROVenus Concept Inc.

No recent price10

APYXApyx Medical Corporation

$2.59-0.38%26

RCELAvita Medical Inc.

$16.32+6.46%30

SIShoulder Innovations, Inc.

$21.01+6.00%35

SSIISS Innovations International, Inc.

$2.27-2.58%40

PDEXPro-Dex Inc.

$63.44+5.31%86

Held by ETFs

CARL is in 2 US ETFs. The largest of them, with CARL's weight in each:

Spot a number that looks wrong? Check it in CARL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CARL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.